Shares of Syneos Health (NASDAQ:SYNH) were unchanged after the company reported Q2 results.
Quarterly Results
Earnings per share were up 67.24% year over year to $0.97, which beat the estimate of $0.96.
Revenue of $1,282,600,000 higher by 26.61% from the same period last year, which beat the estimate of $1,270,000,000.
Looking Ahead
The upcoming fiscal year's EPS expected to be between $4.25 and $4.43.
The upcoming fiscal year's revenue expected to be between $5,180,000,000 and $5,300,000,000.
How To Listen To The Conference Call
Date: Aug 09, 2021
Time: 08:00 AM
ET Webcast URL: https://www.directeventreg.com/der/validateConferenceId.action
Recent Stock Performance
52-week high: $92.25
Company's 52-week low was at $50.27
Price action over last quarter: Up 2.82%
Company Overview
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
